Skip to content

Yuviwel

Published: July 26, 2026Updated: August 25, 2026

Yuvezzi is a brand-name medication used to treat osteoporosis in postmenopausal women who are at high risk for bone fractures. It contains the active ingredient abaloparatide, which is a synthetic analog that works by stimulating bone formation. This medication is typically prescribed when other osteoporosis treatments have not been effective or are not suitable.

Quick summary

Yuvezzi is a prescription injectable medication for postmenopausal women with osteoporosis at high risk for fractures that helps build new bone.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

RxNorm
2736934
Generic
Yuvezzi
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Yuvezzi is indicated for the treatment of osteoporosis in postmenopausal women with high risk of fracture. It is generally recommended for patients who have either failed other osteoporosis therapies or cannot tolerate other treatment options.

Yuvezzi contains abaloparatide, a synthetic analog of parathyroid hormone-related protein (PTHrP). It acts as an agonist at the parathyroid hormone (PTH) receptor, stimulating new bone formation by increasing bone mass and improving bone microarchitecture.

Yuvezzi is administered as a subcutaneous injection, typically once daily. It carries a boxed warning due to a potential increased risk of osteosarcoma observed in animal studies. Patients should be counseled about symptoms of hypercalcemia. Treatment duration is generally limited, and use should be under the supervision of a healthcare provider experienced in treating osteoporosis.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy